Alzheimer’s Disease/Dementia News

SAN DIEGO — A once-weekly dose of transdermal donepezil proved a safe and effective equivalent to a daily dose of oral donepezil for Alzheimer’s-related dementia, per a presenter at the Alzheimer’s Association International Conference.

SAN DIEGO — Substantial unmet end-of-life care needs among older adults with dementia exist in traditionally underrepresented groups compared with white individuals, according to a presenter at the Alzheimer’s Association International Conference.

SAN DIEGO — Cognitive reserve acted as a protective factor that preserved executive function in older adults with benefits mitigated by depression level, according to a presentation at the Alzheimer’s Association International Conference.

SAN DIEGO – Individuals caring for those with dementia “surprisingly” experienced reduced anxiety and depression during the COVID-19 related lockdowns, per a presentation at the Alzheimer’s Association International Conference.

A consortium led by Weill Cornell Medicine has been awarded a $14.7 million NIH grant for its research center, which focuses on emerging and existing technologies that provide support for older adults with cognitive impairments.

Cognivue, a neuroscience company, announced it will launch a national study to differentiate the effectiveness of its cognitive assessment systems.

McLean Hospital in Belmont, Massachusetts, has been named the top hospital in the United States for psychiatric care by the U.S. News & World Report for 2022 to 2023.

Dementia cases in the United States were largely associated with modifiable risk factors, such as hypertension, obesity and physical inactivity — especially among Black and Hispanic people, researchers reported in JAMA Network Open.

The NIH awarded a $45 million grant over 5 years to Burke Neurological Institute to evaluate benfotiamine, a synthetic precursor of thiamine, as a potential therapy for mild Alzheimer’s disease or mild cognitive impairment.

The NIH has awarded researchers at the University of Illinois Urbana-Champaign more than $420,000 to develop ultrasound imaging methods to study neurovascular changes underlying Alzheimer’s disease.